{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:54:56Z","timestamp":1785876896999,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Zhejiang Provincial Medical and Health Science and Technology Program","award":["2022KY1110"],"award-info":[{"award-number":["2022KY1110"]}]},{"name":"the \u201cNew Feather\u201d Talent Program of the First Affiliated Hospital of Ningbo University","award":["XYJH-1-WJQ"],"award-info":[{"award-number":["XYJH-1-WJQ"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43501-z","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:15:48Z","timestamp":1773173748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The key m6A methylation regulator IGF2BP1 possesses potential prognostic value in papillary thyroid carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Jinqiu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingze","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"43501_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/jcm14010028","volume":"14","author":"P Fwelo","year":"2024","unstructured":"Fwelo, P. et al. Impact of American Thyroid Association\u2019s Revised Cancer Management Guidelines on Thyroid Cancer Incidence Trends: A Retrospective Cohort Study, 2000\u20132020. J. Clin. Med. 14, 28. https:\/\/doi.org\/10.3390\/jcm14010028 (2024).","journal-title":"J. Clin. Med."},{"key":"43501_CR2","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.3390\/ijms231911516","volume":"23","author":"L Allegri","year":"2022","unstructured":"Allegri, L., Baldan, F., Molteni, E., Mio, C. & Damante, G. Role of m6A RNA Methylation in Thyroid Cancer Cell Lines. Int. J. Mol. Sci. 23, 11516. https:\/\/doi.org\/10.3390\/ijms231911516 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"43501_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12935-020-01283-y","volume":"20","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer. Cancer Cell. Int. 20, 203. https:\/\/doi.org\/10.1186\/s12935-020-01283-y (2020).","journal-title":"Cancer Cell. Int."},{"key":"43501_CR4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K. & Haymart, M. R. Thyroid cancer. Lancet 401, 1531\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X (2023).","journal-title":"Lancet"},{"key":"43501_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1530\/ERC-22-0151","volume":"29","author":"S Hescot","year":"2022","unstructured":"Hescot, S. et al. Prognostic of recurrence and survival in poorly differentiated thyroid cancer. Endocr. Relat. Cancer. 29, 625\u2013634. https:\/\/doi.org\/10.1530\/ERC-22-0151 (2022).","journal-title":"Endocr. Relat. Cancer"},{"key":"43501_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/cancers14020332","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. & Peng, H. The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies. Cancers (Basel). 14, 332. https:\/\/doi.org\/10.3390\/cancers14020332 (2022).","journal-title":"Cancers (Basel)"},{"key":"43501_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jare.2024.04.016","volume":"70","author":"L Zhao","year":"2025","unstructured":"Zhao, L. et al. Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application. J. Adv. Res. 70, 159\u2013186. https:\/\/doi.org\/10.1016\/j.jare.2024.04.016 (2025).","journal-title":"J. Adv. Res."},{"key":"43501_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41417-020-0160-4","volume":"27","author":"L Melstrom","year":"2020","unstructured":"Melstrom, L. & Chen, J. RNA N6-methyladenosine modification in solid tumors: new therapeutic frontiers. Cancer Gene Ther. 27, 625\u2013633. https:\/\/doi.org\/10.1038\/s41417-020-0160-4 (2020).","journal-title":"Cancer Gene Ther."},{"key":"43501_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41541-025-01118-9","volume":"10","author":"BA Shah","year":"2025","unstructured":"Shah, B. A. et al. Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer. NPJ Vaccines. 10, 68. https:\/\/doi.org\/10.1038\/s41541-025-01118-9 (2025).","journal-title":"NPJ Vaccines"},{"key":"43501_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1158\/2326-6066.CIR-24-0589","volume":"13","author":"Y Weng","year":"2025","unstructured":"Weng, Y. et al. Spatial Organization of Macrophages in CTL-Rich Hepatocellular Carcinoma Influences CTL Antitumor Activity. Cancer Immunol. Res. 13, 310\u2013322. https:\/\/doi.org\/10.1158\/2326-6066.CIR-24-0589 (2025).","journal-title":"Cancer Immunol. Res."},{"key":"43501_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-023-00429-8","volume":"12","author":"JJ Wang","year":"2023","unstructured":"Wang, J. J. et al. Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells. Exp. Hematol. Oncol. 12, 75. https:\/\/doi.org\/10.1186\/s40164-023-00429-8 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"43501_CR12","doi-asserted-by":"publisher","first-page":"153758","DOI":"10.1016\/j.tox.2024.153758","volume":"503","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. The m6A reader IGF2BP1 attenuates the stability of RPL36 and cell proliferation to mediate benzene hematotoxicity by recognizing m6A modification. Toxicology 503, 153758. https:\/\/doi.org\/10.1016\/j.tox.2024.153758 (2024).","journal-title":"Toxicology"},{"key":"43501_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.7150\/thno.49345","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression. Theranostics 11, 1100\u20131114. https:\/\/doi.org\/10.7150\/thno.49345 (2021).","journal-title":"Theranostics"},{"key":"43501_CR14","doi-asserted-by":"publisher","first-page":"e20659","DOI":"10.1016\/j.heliyon.2023.e20659","volume":"9","author":"H Tang","year":"2023","unstructured":"Tang, H., Zhao, J. & Liu, J. Comprehensive analysis of the expression of the IGF2BPs gene family in head and neck squamous cell carcinoma: Association with prognostic value and tumor immunity. Heliyon 9, e20659. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20659 (2023).","journal-title":"Heliyon"},{"key":"43501_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41379-020-0630-0","volume":"34","author":"J Haase","year":"2021","unstructured":"Haase, J. et al. IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod. Pathol. 34, 32\u201341. https:\/\/doi.org\/10.1038\/s41379-020-0630-0 (2021).","journal-title":"Mod. Pathol."},{"key":"43501_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00432-020-03401-9","volume":"147","author":"BY Hernandez","year":"2021","unstructured":"Hernandez, B. Y. et al. BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis. J. Cancer Res. Clin. Oncol. 147, 183\u2013194. https:\/\/doi.org\/10.1007\/s00432-020-03401-9 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"43501_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12885-022-09550-z","volume":"22","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma. BMC Cancer. 22, 461. https:\/\/doi.org\/10.1186\/s12885-022-09550-z (2022).","journal-title":"BMC Cancer"},{"key":"43501_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3892\/ol.2018.9572","volume":"17","author":"C Zhou","year":"2019","unstructured":"Zhou, C., Li, J., Wang, Y., Xue, S. & Zhang, Y. Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma. Oncol. Lett. 17, 183\u2013194. https:\/\/doi.org\/10.3892\/ol.2018.9572 (2019).","journal-title":"Oncol. Lett."},{"key":"43501_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang, X. et al. The role of m6A modification in the biological functions and diseases. Signal. Transduct. Target. Ther. 6, 74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"43501_CR20","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.amjoto.2020.102547","volume":"41","author":"J Hou","year":"2020","unstructured":"Hou, J., Shan, H., Zhang, Y., Fan, Y. & Wu, B. m(6)A RNA methylation regulators have prognostic value in papillary thyroid carcinoma. Am. J. Otolaryngol. 41, 102547. https:\/\/doi.org\/10.1016\/j.amjoto.2020.102547 (2020).","journal-title":"Am. J. Otolaryngol."},{"key":"43501_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3760\/cma.j.cn371439-20200923-00017","volume":"48","author":"ZF He","year":"2021","unstructured":"He, Z. F., Pei, T. M. & Meng, Q. H. IGF2BP1 and cancer. Int. J. Oncol. 48, 92\u201395. https:\/\/doi.org\/10.3760\/cma.j.cn371439-20200923-00017 (2021).","journal-title":"Int. J. Oncol."},{"key":"43501_CR22","doi-asserted-by":"publisher","first-page":"e47074","DOI":"10.15252\/embr.201847074","volume":"20","author":"P Chatterji","year":"2019","unstructured":"Chatterji, P. et al. Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1\/IGF2BP1. EMBO Rep. 20, e47074. https:\/\/doi.org\/10.15252\/embr.201847074 (2019).","journal-title":"EMBO Rep."},{"key":"43501_CR23","doi-asserted-by":"publisher","first-page":"15690","DOI":"10.18632\/oncotarget.7464","volume":"7","author":"G Wang","year":"2016","unstructured":"Wang, G. et al. IMP1 suppresses breast tumor growth and metastasis through the regulation of its target mRNAs. Oncotarget 7, 15690\u201315702. https:\/\/doi.org\/10.18632\/oncotarget.7464 (2016).","journal-title":"Oncotarget"},{"key":"43501_CR24","doi-asserted-by":"publisher","first-page":"e210024","DOI":"10.1530\/ETJ-21-0024","volume":"11","author":"J Bogus\u0142awska","year":"2022","unstructured":"Bogus\u0142awska, J., Godlewska, M., Gajda, E. & Piekie\u0142ko-Witkowska, A. Cellular and molecular basis of thyroid autoimmunity. Eur. Thyroid J. 11, e210024. https:\/\/doi.org\/10.1530\/ETJ-21-0024 (2022).","journal-title":"Eur. Thyroid J."},{"key":"43501_CR25","doi-asserted-by":"publisher","unstructured":"HommaY SY13-2 - Immunotherapy with molecular targeted drug for thyroid cancer. Ann. Oncol. 30 (vi38). https:\/\/doi.org\/10.1093\/annonc\/mdz344 (2019).","DOI":"10.1093\/annonc\/mdz344"},{"key":"43501_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12967-023-04532-6","volume":"21","author":"S Ji","year":"2023","unstructured":"Ji, S. et al. Cancer stem cell-derived CHI3L1 activates the MAF\/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer. J. Transl Med. 21, 721. https:\/\/doi.org\/10.1186\/s12967-023-04532-6 (2023).","journal-title":"J. Transl Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43501-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:37:52Z","timestamp":1773221872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43501-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43501"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43501-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Ningbo University (Approval No. 2021-R140, dated December 30, 2021). All TCGA data used in this study are publicly available through the National Cancer Institute\u2019s Genomic Data Commons portal (\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"8699"}}